Picture of Optipharm Co logo

153710 Optipharm Co Cashflow Statement

0.000.00%
kr flag iconLast trade - 00:00
HealthcareAdventurousSmall CapSucker Stock

Annual cashflow statement for Optipharm Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:Annual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited Accounts
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-655-2,352-3,080-2,045-2,437
Depreciation
Amortisation
Non-Cash Items-39.1-679-1,181-1,32665.6
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital2854301,215-184-785
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities447-1,617-1,969-2,434-1,723
Capital Expenditures-755-955-757-4,604-1,737
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items-5,201-3,002-6,6302,665-1,852
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-5,956-3,956-7,387-1,939-3,589
Financing Cash Flow Items-109-135-156-130-147
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities-5841,1061,8191,7601,993
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-6,093-4,467-7,538-2,613-3,319